NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

MUSCLE & NERVE is a prestigious journal dedicated to the exploration and advancement of knowledge in the fields of neurology, cellular and molecular neuroscience, and physiology. Published by Wiley, this journal has been a crucial resource for researchers and practitioners since its inception in 1978, with an impressive convergence of studies anticipated through 2024. With an Impact Factor reflecting its relevance and influence—ranking in the Q2 and Q3 quartiles across multiple categories, including clinical neurology and medical physiology—MUSCLE & NERVE offers a rigorous peer-reviewed platform for groundbreaking research. It holds a respected position in Scopus rankings, illustrating its commitment to excellence and innovation in medicine and neuroscience. As a non-open access journal, it provides valuable resources for professionals seeking to further their understanding of neuromuscular physiology and related disciplines. The journal aims to foster dialogue and disseminate knowledge that advances the field, making it an indispensable tool for academics and clinicians alike.

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, published by JMNI in Greece, serves as a vital platform for disseminating cutting-edge research in the fields of musculoskeletal and neuronal sciences. Established in 2002, this journal has continued to evolve, presenting studies that bridge the critical interactions between musculoskeletal health and neuronal function. With a current impact factor reflected in its rankings, it holds a Q3 classification in Endocrinology, Diabetes and Metabolism, and a Q2 classification in Orthopedics and Sports Medicine, alongside Q3 in Physiology, placing it prominently within the academic landscape. The journal's accessibility, while not officially labeled as Open Access, ensures that valuable research findings are available to an international audience of researchers, professionals, and students committed to advancing the understanding of human health. The depth and breadth of content in the JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS underscore its importance in fostering innovation and collaboration across related disciplines, making it a must-read for those invested in the future of musculoskeletal and neuronal research.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.

Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.

EUROPEAN JOURNAL OF NEUROLOGY, published by WILEY, stands as a leading platform for the dissemination of innovative research and clinical developments in the field of neurology. With a robust impact factor and prestigious rankings, including being positioned as Q1 in both Neurology and Clinical Neurology categories, the journal plays a pivotal role in shaping neurological sciences from 1994 to 2024. Its Scopus rank highlights its importance, being in the 88th percentile for clinical neurology and 87th percentile for neuroscience. Located in the United Kingdom, the journal thrives as a vital resource for researchers, clinicians, and students dedicated to improving neurological health outcomes. Although it does not offer Open Access, its subscription-based model ensures high-quality peer-reviewed articles are accessible to a global audience, reflecting the continuous pursuit of excellence in neurological research and patient care.

DYSPHAGIA, published by Springer, is a premier journal dedicated to advancing the study of swallowing disorders, a critical area within the fields of Gastroenterology, Otorhinolaryngology, and Speech and Hearing. With an ISSN of 0179-051X and E-ISSN 1432-0460, this journal serves as a vital resource for researchers, clinicians, and students alike, providing cutting-edge research and reviews that inform clinical practice and enhance patient care. As a testament to its influence, DYSPHAGIA holds a Q2 ranking in Gastroenterology and Q1 rankings in both Otorhinolaryngology and Speech and Hearing for 2023. Its Scopus rankings further position it among the leading journals in its field, highlighting its importance and impact within the academic community. The journal publishes contributions that encompass a spectrum of topics related to swallowing, making it an essential platform for disseminating knowledge and fostering innovative solutions in the management of dysphagia. Operating from New York, NY, DYSPHAGIA invites contributions that align with its mission to advance the understanding and treatment of swallowing disorders through rigorous scientific inquiry and discourse.